2GHV
Crystal structure of SARS spike protein receptor binding domain
Summary for 2GHV
| Entry DOI | 10.2210/pdb2ghv/pdb |
| Related | 2ajf 2ghw |
| Descriptor | Spike glycoprotein (2 entities in total) |
| Functional Keywords | sars, s protein, viral protein |
| Biological source | SARS coronavirus |
| Cellular location | Virion membrane; Single-pass type I membrane protein: P59594 |
| Total number of polymer chains | 2 |
| Total formula weight | 45767.66 |
| Authors | Hwang, W.C.,Lin, Y.,Santelli, E.,Sui, J.,Jaroszewski, L.,Stec, B.,Farzan, M.,Marasco, W.A.,Liddington, R.C. (deposition date: 2006-03-27, release date: 2006-09-19, Last modification date: 2024-11-20) |
| Primary citation | Hwang, W.C.,Lin, Y.,Santelli, E.,Sui, J.,Jaroszewski, L.,Stec, B.,Farzan, M.,Marasco, W.A.,Liddington, R.C. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J.Biol.Chem., 281:34610-34616, 2006 Cited by PubMed Abstract: Severe acute respiratory syndrome (SARS) is a newly emerged infectious disease that caused pandemic spread in 2003. The etiological agent of SARS is a novel coronavirus (SARS-CoV). The coronaviral surface spike protein S is a type I transmembrane glycoprotein that mediates initial host binding via the cell surface receptor angiotensin-converting enzyme 2 (ACE2), as well as the subsequent membrane fusion events required for cell entry. Here we report the crystal structure of the S1 receptor binding domain (RBD) in complex with a neutralizing antibody, 80R, at 2.3 A resolution, as well as the structure of the uncomplexed S1 RBD at 2.2 A resolution. We show that the 80R-binding epitope on the S1 RBD overlaps very closely with the ACE2-binding site, providing a rationale for the strong binding and broad neutralizing ability of the antibody. We provide a structural basis for the differential effects of certain mutations in the spike protein on 80R versus ACE2 binding, including escape mutants, which should facilitate the design of immunotherapeutics to treat a future SARS outbreak. We further show that the RBD of S1 forms dimers via an extensive interface that is disrupted in receptor- and antibody-bound crystal structures, and we propose a role for the dimer in virus stability and infectivity. PubMed: 16954221DOI: 10.1074/jbc.M603275200 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report






